With clinical trials supporting psychedelics, like psilocybin mushrooms for the treatment of obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, depression and anxiety, it’s only a matter of time before big pharmaceutical companies begin to invest heavily, and incorporate psychedelics into their own drug pipelines.
Mind Cure's nootropic products are set to launch across 17 locations within North America starting Feb, 2021.
Health Canada issues its first Section 56 Exemption for psilocybin use to an Alberta resident.
MIKE TYSON caused a stir after scoffing four grams of magic mushrooms on Logan Paul’s podcast.
Victims of racism should take Ecstasy or magic mushrooms to reduce the trauma of their experience, suggests a new study.
Canada has an international reputation for progressive health policies, take for example its publicly funded healthcare program and its assisted dying laws. It also led the way in drug reform when it became the first G7 country to legalize cannabis in 2018.
After a great year in 2020, psychedelic drug stocks are poised for an even better year in 2021.
Mind Cure announces a health-and-wellness supplement to support teen mental health.
Two of the most powerful voices in new media are advocating for the mental health benefits of psychedelics in a big way.
VANCOUVER, BC, Dec. 29, 2020 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA" or the "Company") is pleased to announce that it has added two additional psychedelic compounds to its drug portfolio.
While many 2020 memories will be gladly left behind, that's not necessarily the case for psychedelics.
2020 was a very good year for the psychedelic drug industry. Psychedelic Stock Watch has compiled our own Report Card on industry performance.
Investing in the best psychedelic stocks today could be like getting in on the ground floor of the medical marijuana industry.
NEW YORK, Dec. 21, 2020 /PRNewswire/ -- Investments continued flowing into the psychedelic medicine sector this year and will likely continue in 2021 as mental illness cases rise across the globe.
Psychedelic drugs have the potential to revolutionize mental health care while simultaneously saving the global economy $100s of billions each year.
